Riskpilot← Back to searchSign inGet full accessColosseum Virum ApS
APSActiveCVR 39711915Herlev Bygade 14, 1.Dental practice care activities · NACE 8623Est. 20185 employees
Revenue 2024
DKK 4,2M
-33% vs 2023
EBITDA margin
-3.2%
-119% vs 2023
Equity ratio
54.5%
Financial strength
Net profit 2024
DKK -3,1M
-1834% vs 2023
| Revenue | DKK 4,2M | -33% |
| EBITDA | DKK -135K | -119% |
| Net profit | DKK -3,1M | -1834% |
| Total assets | DKK 2,5M | -57% |
| Equity | DKK 1,4M | -69% |
| Employees | 5 | — |
Legal name
Colosseum Virum ApS
CVR number
39711915
Legal form
Anpartsselskab
NACE code
8623 · Dental practice care activities
Founded
4. juli 2018
Share capital
DKK 50.000
Employees
5 (FTE)
VAT registered
No
Audit selected
Yes
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af den administrerende direktør i forening med bestyrelsesformanden
Company purpose
Selskabets formål er at drive tandlægevirksomhed og virksomhed, der er naturligt forbundet hermed
Address
Herlev Bygade 14, 1.
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | 397 | 5.459 | 6.273 | 5.952 | 6.796 | 6.279 | 4.205 |
| Staff expenses | -355 | -4.862 | -5.425 | -5.241 | -6.139 | -5.568 | -4.341 |
| EBITDA | 42 | 597 | 849 | 711 | 657 | 710 | -135 |
| Depreciation & amort. | -54 | -708 | -736 | -647 | -702 | -855 | -2.960 |
| EBIT | -12 | -110 | 113 | 64 | -45 | -144 | -3.096 |
| Net financials | -4 | -10 | -18 | -12 | -17 | -15 | -33 |
| Profit before tax | -17 | -121 | 95 | 53 | -62 | -159 | -3.128 |
| Tax | -4 | -27 | 54 | 58 | -0 | -0 | -45 |
| Net profit | -13 | -94 | 41 | -5 | -62 | -159 | -3.083 |
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Total assets | 6.497 | 6.362 | 6.928 | 6.468 | 6.077 | 5.804 | 2.521 |
| Equity | 4.737 | 4.643 | 4.683 | 4.678 | 4.617 | 4.457 | 1.374 |
| Long-term debt | 0 | 85 | 207 | 207 | 207 | 207 | 233 |
| Short-term debt | 1.760 | 1.634 | 2.037 | 1.583 | 1.254 | 1.140 | 914 |
| Total debt | 1.760 | 1.719 | 2.244 | 1.790 | 1.461 | 1.346 | 1.147 |
EBITDA margin
-3.2%
This company
15.8%
Market median
-120% vs market
20182024
Equity ratio
54.5%
This company
38.2%
Market median
+43% vs market
20182024
Return on equity
-224.4%
This company
18.4%
Market median
-1320% vs market
20182024
Net profit margin
-73.3%
This company
8.1%
Market median
-1005% vs market
20182024
Asset turnover
1.67×
This company
1.12×
Market median
+49% vs market
20182024
Debt / equity
0.83×
This company
0.62×
Market median
+34% vs market
20182024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-07-04 – 2018-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
MB Chief Executive Officer | Chief Executive Officer | 2025 | — | — |
MR Chief Executive Officer | Chief Executive Officer | 2025 | — | — |
HH Chief Executive Officer | Chief Executive Officer | 2018 | — | — |
FM Management | Management | 2018 | — | — |
LH Management | Management | 2023 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Board of Directors | 2018 | — | — | |
| Board of Directors | 2019 | — | — | |
| Chairman | 2018 | — | — | |
| Board of Directors | 2025 | — | — | |
| Chairman | 2018 | — | — | |
| Board of Directors | 2018 | — | — | |
| Board of Directors | 2018 | — | — | |
| Chairman | 2021 | — | — | |
| Board of Directors | 2025 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Tandlægerne HHEH Holding ApS | Company | 100.0% | 100.0% | 2018 |
Ehlers-Hansen Holding ApS | Company | 50.0% | 50.0% | 2022 |
Tandlæge Lars Rossel Holding ApS | Company | 50.0% | 50.0% | 2023 |
Tandlægeholding- og investeringsselskabet Ehlers-Hansen ApS | Company | 50.0% | 50.0% | 2018 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
COLOSSEUMKLINIKKEN DANMARK ApSCRSG Denmark ApSTandlægerne HHEH Holding ApS
Colosseum Virum ApS (this company)Board members of Colosseum Virum ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Malin Birgitta Schmidt | Chief Executive Officer | 0 companies |
| Mathias Riis Damgaard | Chief Executive Officer | 0 companies |
| Henrik Holger Ehlers-Hansen | Chief Executive Officer | 0 companies |
| Frans Maarten van Berckel | Management | 0 companies |
| Lars Hovmand Rossel | Management | 0 companies |
| Jerry Mathen George | Board of Directors | 0 companies |
| Rasmus Maahr | Board of Directors | 0 companies |
| Jacob Adelbertus Cornelis Vermeule | Chairman | 0 companies |
| Christian Rydiander Toelhøj | Board of Directors | 0 companies |
| Søren Kock | Chairman | 0 companies |
| Dominique Nicole Dr. Friederich | Board of Directors | 0 companies |
| Mette Ehlers-Hansen | Board of Directors | 0 companies |
| Jens Mondrup | Chairman | 0 companies |
| Christopher Sebastian Östberg | Board of Directors | 0 companies |